Isbn: 9789819550708 - enzyme based approaches in cancer healthcare management (9 résultats)

Affiner la recherche

  • Livres (9)

à

Fourchette de prix personnalisée (EUR)

à

  • Langue : anglais

    Edité par Springer, 2026

    981955070X / 9789819550708

    • Couverture rigide

    Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books

    Vendeur avec une évaluation de 4 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 233,31

     Frais de port gratuits 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • Langue : anglais

    Edité par Springer Verlag GmbH, 2026

    981955070X / 9789819550708

    • Couverture rigide

    Vendeur : moluna, Greven, Allemagnemoluna

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 225,91

    EUR 48,99 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • Langue : anglais

    Edité par Springer, 2026

    981955070X / 9789819550708

    • Couverture rigide

    Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 297,68

    EUR 30,50 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible(s)

    Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This book offers an in-depth analysis of enzyme-based approaches in healthcare management, focusing on their transformative potential in cancer treatment. This volume delves into the intricate roles of enzymes in cancer progression and targeted therapy.The book addresses a wide range of subjects, such as the functions of important enzymes in the biology of cancer, developments in targeting telomerase, the cell cycle, angiogenesis, and metastasis, and the possibility of using topoisomerase and PARP inhibitors to take advantage of weaknesses in cancer cells. It provides an in-depth analysis of non-glycolytic and glycolytic enzymes, tumor-driven angiogenesis, epigenetic regulation, and advanced therapeutic approaches, including nanotechnology and bispecific antibodies. It addresses key questions such as how enzymes contribute to cancer metabolism and how novel therapeutic strategies can exploit these pathways for more accurate and less dangerous cancer medicines. The book covers expert analyses of key enzymes involved in cancer biology, including hexokinase, phosphofructokinase-1, and matrix metalloproteinases.This book is an invaluable resource for researchers, clinicians, and professionals in the pharmaceutical and biotechnology industries. It offers a comprehensive overview of the molecular mechanisms underlying enzyme function in cancer and the development of innovative enzyme-targeted treatments. It is a must-read for those seeking to advance their understanding of enzyme-based healthcare management.

  • 981955070X / 9789819550708

    Vendeur : GreatBookPrices, Columbia, MD, Etats-UnisGreatBookPrices

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 230,93

    EUR 2,30 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • 981955070X / 9789819550708

    Vendeur : GreatBookPricesUK, Woodford Green, Royaume-UniGreatBookPricesUK

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 238,39

    EUR 17,50 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • 981955070X / 9789819550708

    Vendeur : GreatBookPricesUK, Woodford Green, Royaume-UniGreatBookPricesUK

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Occasion - Comme neuf

    EUR 253,96

    EUR 17,50 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : As New. Unread book in perfect condition.

  • Langue : anglais

    Edité par Springer, Springer Jan 2026, 2026

    981955070X / 9789819550708

    • Couverture rigide
    • impression à la demande

    Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AllemagneBuchWeltWeit Ludwig Meier e.K.

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 213,99

    EUR 23,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponible(s)

    Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book offers an in-depth analysis of enzyme-based approaches in healthcare management, focusing on their transformative potential in cancer treatment. This volume delves into the intricate roles of enzymes in cancer progression and targeted therapy.The book addresses a wide range of subjects, such as the functions of important enzymes in the biology of cancer, developments in targeting telomerase, the cell cycle, angiogenesis, and metastasis, and the possibility of using topoisomerase and PARP inhibitors to take advantage of weaknesses in cancer cells. It provides an in-depth analysis of non-glycolytic and glycolytic enzymes, tumor-driven angiogenesis, epigenetic regulation, and advanced therapeutic approaches, including nanotechnology and bispecific antibodies. It addresses key questions such as how enzymes contribute to cancer metabolism and how novel therapeutic strategies can exploit these pathways for more accurate and less dangerous cancer medicines. The book covers expert analyses of key enzymes involved in cancer biology, including hexokinase, phosphofructokinase-1, and matrix metalloproteinases.This book is an invaluable resource for researchers, clinicians, and professionals in the pharmaceutical and biotechnology industries. It offers a comprehensive overview of the molecular mechanisms underlying enzyme function in cancer and the development of innovative enzyme-targeted treatments. It is a must-read for those seeking to advance their understanding of enzyme-based healthcare management. 480 pp. Englisch.

  • Langue : anglais

    Edité par Springer, Springer Jan 2026, 2026

    981955070X / 9789819550708

    • Couverture rigide
    • impression à la demande

    Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagnebuchversandmimpf2000

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 213,99

    EUR 60,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible(s)

    Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book offers an in-depth analysis of enzyme-based approaches in healthcare management, focusing on their transformative potential in cancer treatment. This volume delves into the intricate roles of enzymes in cancer progression and targeted therapy.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 480 pp. Englisch.

  • Langue : anglais

    Edité par Springer Verlag, Singapore, Singapore, 2026

    981955070X / 9789819550708

    • Couverture rigide
    • impression à la demande

    Vendeur : CitiRetail, Stevenage, Royaume-UniCitiRetail

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 242,08

    EUR 43,16 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 1 disponible(s)

    Hardcover. Etat : new. Hardcover. This book offers an in-depth analysis of enzyme-based approaches in healthcare management, focusing on their transformative potential in cancer treatment. This volume delves into the intricate roles of enzymes in cancer progression and targeted therapy.The book addresses a wide range of subjects, such as the functions of important enzymes in the biology of cancer, developments in targeting telomerase, the cell cycle, angiogenesis, and metastasis, and the possibility of using topoisomerase and PARP inhibitors to take advantage of weaknesses in cancer cells. It provides an in-depth analysis of non-glycolytic and glycolytic enzymes, tumor-driven angiogenesis, epigenetic regulation, and advanced therapeutic approaches, including nanotechnology and bispecific antibodies. It addresses key questions such as how enzymes contribute to cancer metabolism and how novel therapeutic strategies can exploit these pathways for more accurate and less dangerous cancer medicines. The book covers expert analyses of key enzymes involved in cancer biology, including hexokinase, phosphofructokinase-1, and matrix metalloproteinases.This book is an invaluable resource for researchers, clinicians, and professionals in the pharmaceutical and biotechnology industries. It offers a comprehensive overview of the molecular mechanisms underlying enzyme function in cancer and the development of innovative enzyme-targeted treatments. It is a must-read for those seeking to advance their understanding of enzyme-based healthcare management. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.